A SYSTEMATIC REVIEW OF COST-EFFECTIVENESS ANALYSIS (CEA) STUDIES FROM THE PATIENT'S PERSPECTIVE

Author(s)

Tai BB1, Bae YH2, Le Q2
1Khoo Teck Puat Hospital (Alexandra Health Pte Ltd), Singapore, Singapore, 2WESTERN UNIVERSITY OF HEALTH SCIENCES, POMONA, CA, USA

OBJECTIVES: Patient-centered outcomes have become increasingly important and relevant in making informed healthcare decisions. However, the influence of patient’s perspective in economic evaluation studies remains unknown. This study sought to systematically review CEA studies conducted from the patient’s perspective. METHODS: PUBMED, EMBASE, and Cochrane Central database were searched through May 2014 for CEA studies that used patient’s perspective. Essential characteristics of these economic studies were extracted and compared. The reporting quality of these studies was evaluated using the ISPOR guideline, Consolidated Health Economic Evaluation Reporting Standards (CHEERS). RESULTS: A total of 21 out of 32 studies retrieved met the inclusion criteria. These studies, in average, met 17 of 24 reporting criteria specified in CHEERS, and were conducted in the US (5), Europe (6), Asia (6), and others (4). Among the 21 CEA studies, 9 evaluated pharmacotherapy and 12 non-drug intervention. Of the 8 studies that mentioned reasons for using patient’s perspective, patient’s consideration of financial burden associated with medical intervention was the most common one (7), followed by possible influence on patient adherence and utilization of resources (1). Societal (3), government (1), institutional (12), or third-party payer (2) perspectives were also used in majority of the studies. Direct medical cost generally considered in the studies were out-of-pocket costs such as copayment or co-insurance for drugs, office visits, tests, and procedures, whereas direct non-medical cost included travel and food cost. Sensitivity analyses were performed in 19 studies, and governmental agencies or university grants were the most common funding sources (14) disclosed by17 studies. CONCLUSIONS: Currently, there is a paucity of CEA studies conducted from patient’s perspective in the literature, and the reporting quality of these studies was not optimal. With the increasing focus of patient-centered outcomes in health policy research, use of patient’s perspective in economic studies should be advocated.

Conference/Value in Health Info

2015-05, ISPOR 2015, Philadelphia, PA, USA

Value in Health, Vol. 18, No. 3 (May 2015)

Code

PHP64

Topic

Economic Evaluation

Topic Subcategory

Cost-comparison, Effectiveness, Utility, Benefit Analysis

Disease

Multiple Diseases

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×